Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
| Status: | Archived |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), Ocular |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Ophthalmology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | August 2010 |
| End Date: | September 2011 |
This study has 2 parts. Part 1 will evaluate the safety and IOP effects of 6 formulations of
AGN-210961 ophthalmic solution in the study eye and bimatoprost ophthalmic solution 0.03% in
the fellow eye for 7 consecutive days. Part 2 will evaluate the safety and IOP effects of a
formulation (to be selected from part 1) of AGN-210961 in both eyes compared to bimatoprost
ophthalmic solution 0.03% for 4 weeks.
We found this trial at
1
site
Click here to add this to my saved trials
